Krystal Biotech, Inc. (KRYS)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$358.24-3.56%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · KRYS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 440.5 | 389.1 | 290.5 | 50.7 | 0.0 | 0.0 | — | — | — |
| Operating Expenses & Income | |||||||||
| Selling, General & Admin | 159.9 | 146.7 | 113.7 | 98.3 | 77.7 | — | — | — | — |
| R&D Expenses | 59.2 | 58.0 | 53.6 | 46.4 | 42.5 | 27.9 | 17.9 | 15.6 | 3.2 |
| Operating Income | 197.8 | 161.3 | 65.7 | (109.6) | (145.2) | (68.3) | (33.0) | (22.1) | (4.8) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | — | — | 0.0 | 0.0 | 1.5 | 0.0 | — | — |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | (3.1) |
| EBT, Incl. Unusual Items | 226.6 | 189.5 | 95.4 | 12.9 | (140.0) | (69.6) | — | — | — |
| Income Tax Expense | (14.8) | (15.4) | 6.2 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||||
| Net Income | 241.5 | 204.8 | 89.2 | 10.9 | (140.0) | (69.6) | (32.2) | (19.1) | (7.9) |
| Per Share | |||||||||
| Basic EPS | 8.18 | 7.08 | 3.12 | 0.40 | (5.49) | (3.13) | (1.71) | — | — |
| Diluted EPS | 7.88 | 6.84 | 3.00 | 0.39 | (5.49) | (3.13) | (1.71) | — | — |
| Revenue per Share | 14.37 | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 29.5 | 28.9 | 28.6 | 27.2 | 25.5 | 22.2 | 18.8 | — | — |
| Diluted Weighted Avg Shares | 30.7 | 30.0 | 29.7 | 27.8 | 25.5 | 22.2 | 18.8 | — | — |
| Supplemental | |||||||||
| EBITDA | — | — | — | — | (141.1) | (65.5) | (31.1) | — | — |
| EBIT | 197.8 | 161.3 | 65.7 | (109.6) | (145.2) | (68.3) | (33.0) | (22.1) | (4.8) |
| Effective Tax Rate | -6.6% | — | — | 15.2% | 0.0% | 0.0% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.